Ghent University Academic Bibliography

Advanced

Post-mortem (re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'): human and animal data

Els De Letter UGent, Christophe Stove UGent, Willy Lambert UGent and Michel Piette UGent (2010) CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 11(5). p.453-459
abstract
In this paper, the distribution and redistribution of the amphetamine derivative, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is brought into focus. Animal experimental data were compared with internationally reported MDMA-related human fatalities: in general, these turned out to be parallel with each other. Due to its inherent properties (e. g. significant volume of distribution), MDMA is liable to postmortem redistribution. Indeed, very high concentrations have been found in cardiac blood and tissues located centrally in the body (blood-rich organs such as lungs and liver in particular). This confirms that post-mortem redistribution due to diffusion from higher to lower concentration can easily take place, mainly at longer post-mortem intervals and when putrefaction occurs. Therefore, we can conclude that for post-mortem quantitation of amphetamine and derivatives, and MDMA in particular, peripheral blood sampling (e. g. femoral vein) remains compulsory. However, if the latter is impossible, MDMA quantification in a few alternative matrices such as vitreous humour and iliopsoas muscle may provide additional information to come to a reliable conclusion. Furthermore, it should be stressed that - at present - it is impossible to estimate the individual susceptibility to the various possible adverse effects of MDMA, which implies that it is impossible to provide a "safe" or "therapeutic" blood MDMA level. Therefore, in current forensic practice, the post-mortem pathological and toxicological findings should form an entity in order to draw a well-grounded conclusion.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (review)
publication status
published
subject
keyword
BLOOD-LEVELS, AMPHETAMINE, TISSUE CONCENTRATIONS, 3_4-METHYLENEDIOXYAMPHETAMINE MDA, MDMA, FATAL OVERDOSE, VITREOUS-HUMOR, Ecstasy, 3_4-methylenedioxymethamphetamine, COCAINE, METHAMPHETAMINE, DRUG REDISTRIBUTION, post-mortem distribution, DERIVATIVE RELATED DEATHS, post-mortem redistribution, review, post-mortem toxicology
journal title
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Curr. Pharm. Biotechnol.
volume
11
issue
5
pages
453 - 459
Web of Science type
Review
Web of Science id
000280473800006
JCR category
PHARMACOLOGY & PHARMACY
JCR impact factor
3.455 (2010)
JCR rank
63/249 (2010)
JCR quartile
2 (2010)
ISSN
1389-2010
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1035650
handle
http://hdl.handle.net/1854/LU-1035650
date created
2010-09-01 15:37:13
date last changed
2015-06-17 09:11:54
@article{1035650,
  abstract     = {In this paper, the distribution and redistribution of the amphetamine derivative, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is brought into focus. Animal experimental data were compared with internationally reported MDMA-related human fatalities: in general, these turned out to be parallel with each other. Due to its inherent properties (e. g. significant volume of distribution), MDMA is liable to postmortem redistribution. Indeed, very high concentrations have been found in cardiac blood and tissues located centrally in the body (blood-rich organs such as lungs and liver in particular). This confirms that post-mortem redistribution due to diffusion from higher to lower concentration can easily take place, mainly at longer post-mortem intervals and when putrefaction occurs. Therefore, we can conclude that for post-mortem quantitation of amphetamine and derivatives, and MDMA in particular, peripheral blood sampling (e. g. femoral vein) remains compulsory. However, if the latter is impossible, MDMA quantification in a few alternative matrices such as vitreous humour and iliopsoas muscle may provide additional information to come to a reliable conclusion. Furthermore, it should be stressed that - at present - it is impossible to estimate the individual susceptibility to the various possible adverse effects of MDMA, which implies that it is impossible to provide a {\textacutedbl}safe{\textacutedbl} or {\textacutedbl}therapeutic{\textacutedbl} blood MDMA level. Therefore, in current forensic practice, the post-mortem pathological and toxicological findings should form an entity in order to draw a well-grounded conclusion.},
  author       = {De Letter, Els and Stove, Christophe and Lambert, Willy and Piette, Michel},
  issn         = {1389-2010},
  journal      = {CURRENT PHARMACEUTICAL BIOTECHNOLOGY},
  keyword      = {BLOOD-LEVELS,AMPHETAMINE,TISSUE CONCENTRATIONS,3\_4-METHYLENEDIOXYAMPHETAMINE MDA,MDMA,FATAL OVERDOSE,VITREOUS-HUMOR,Ecstasy,3\_4-methylenedioxymethamphetamine,COCAINE,METHAMPHETAMINE,DRUG REDISTRIBUTION,post-mortem distribution,DERIVATIVE RELATED DEATHS,post-mortem redistribution,review,post-mortem toxicology},
  language     = {eng},
  number       = {5},
  pages        = {453--459},
  title        = {Post-mortem (re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'): human and animal data},
  volume       = {11},
  year         = {2010},
}

Chicago
De Letter, Els, Christophe Stove, Willy Lambert, and Michel Piette. 2010. “Post-mortem (re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Human and Animal Data.” Current Pharmaceutical Biotechnology 11 (5): 453–459.
APA
De Letter, E., Stove, C., Lambert, W., & Piette, M. (2010). Post-mortem (re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”): human and animal data. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 11(5), 453–459.
Vancouver
1.
De Letter E, Stove C, Lambert W, Piette M. Post-mortem (re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”): human and animal data. CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2010;11(5):453–9.
MLA
De Letter, Els, Christophe Stove, Willy Lambert, et al. “Post-mortem (re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Human and Animal Data.” CURRENT PHARMACEUTICAL BIOTECHNOLOGY 11.5 (2010): 453–459. Print.